Walgreens Boots Alliance (WBA) is scheduled to report FQ3’15 earnings before the market opens this Thursday. The Estimize consensus is set at $0.88, only 1 cent higher than the Wall Street consensus. In terms of revenue forecasts, the Estimize consensus is marginally lower than Wall Street’s at $30.27M. Last quarter company EPS and revenue numbers shocked both the Estimize community and the Street, coming in at nearly 14.7% and 4.27% lower than expected, respectively.

Walgreens, the largest drug retailing chain the United States, merged with Switzerland-based Alliance Boots in 2014 to form Walgreens Boots Alliance. The stock has been trading on the NASDAQ since, switching from the ticker WAG to WBA as it has soared to new highs. Year-to-date, the stock has risen 12.72%. The S&P 500 has paled in comparison year-to-date, returning a negative .32%.

At its last quarterly earnings release, Walgreens released revenue numbers of $26.57M, up nearly 35.5% from the same quarter in the previous year. The company has also experienced a massive increase in its Earnings Before Interest and Tax (EBIT) from $1.16M in 2014 to $2.59M in 2015, an increase of roughly 123%. Further bolstering the company’s bullish performance, member of the board of directors John Anthony Lederer purchased 10,000 shares of the company’s stock as filed with the SEC on April 20th of this year.

The company has been growing rapidly since its acquisition of Boots Alliance, and it is expected to continue throughout this fiscal year. Both Citi and Deutsche Bank have both recently rated the stock at a “buy”, and the stock paid a quarterly dividend of $0.33 on June 12th. Be sure to keep an eye out for Walgreens as it looks to post increased earnings at the beginning of the season this Thursday.